Validation of RNA Genetic Testing for Use in a Clinical Diagnostic Setting | Ambry Genetics
For more information about RNA genetic testing, visit: https://www.ambrygen.com/rna
This webinar will cover the developments in clinical genetic testing leading to RNA genetic testing and the relevant technological background.
The molecular biology of RNA splicing that underpins the functional information offered by RNA will be discussed. A targeted and scalable approach to RNA genetic testing in 18 tumor suppressor genes will be described.
The results of this approach in a pilot cohort yielded a relative percent increase in the diagnostic yield, and case studies will be presented that illustrate how RNA contributes to such an increase.
Presented by:
Tyler Landrith, PhD | Presenter
Tara Namey, MS, LCGC | Moderator
Tyler Landrith is an R&D scientist in the Ambry Translational Genomics (ATG) Lab. He joined Ambry in 2017 as a postdoctoral fellow and his work in the ATG lab has focused on assay development for RNA genetic testing. He received his PhD from UC Riverside, where his dissertation work in the Wilson Laboratory employed NGS to develop RNA expression profiles of the immunological memory response to chronic T. gondii infection. He lives in Aliso Viejo with his wife and 16-month old daughter, where he enjoys spending time outdoors with his family.
-
Category
No comments found